Cancer Pharmacology

Investigation determinations in sarcoma pharmacology take account of trainings of the simple instruments of indication transduction related with cell multiplying and apoptosis, the contrivances of achievement of anti-neoplastic agents, the scheme and finding of original drugs, simple contrivances of DNA repair and DNA impairment acceptance and the progress of fresh plans for gene therapy. Importance is hired on the account and classification of elementary signing machines that create the marks of molecules used for cancer therapy and DNA damage and renovation apparatuses that pay to anti-neoplastic drug conflict. The rule of tyrosine kinases, treating of proto-oncogenes, parameter of minor GTPases and their effectors, cell-cycle-specific kinases and DNA repair gene products are actuality studied as possible marks or to improve the efficiency of present chemotherapeutic means. The part of growing elements in the movement of solid and hematopoietic tumors is existence studied; innovative receptors and signal transduction paths are being recognized in usual and malicious tissues.

  • Design and discovery of new drugs
  • Cancer Vaccines
  • Side Effects
  • Precision Oncology
  • Clinical Trial Information
  • Clinical Research

Related Conference of Cancer Pharmacology

March 10-11, 2025

3rd World Congress on Oral Cancer

Paris, France
March 24-25, 2025

25th World Congress on Cancer and Diagnostics

London, UK
March 24-25, 2025

10th World Conference on Breast and Cervical Cancer

Paris, France
April 07-08, 2025

15th World Congress on Breast Cancer

Vancouver, Canada
April 28-29, 2025

35th Experts Meet On Cancer Research & Therapy

Aix-en-Provence, France
June 16-17, 2025

26th World Congress on Cancer Summit

Amsterdam, Netherlands
July 14-15, 2025

5th World Congress on Breast Cancer

Berlin, Germany
October 20-21, 2025

21st International Conference on Cancer Research

Barcelona, Spain

Cancer Pharmacology Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in